Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session I: Current Developments in Colorectal Cancer
Debate: First-Line Treatment in Left-Sided, RAS/BRAF Wild-Type Metastatic Colorectal Cancer: EGFR Inhibitors vs. VEGF Inhibitors - VEGF
Wednesday, November 16, 2022
10:43 AM – 10:51 AM
Debate Speaker(s)
Cathy Eng, MD, FACP, FASCO
Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center